The Combined First Trimester Screening
Condition(s) studied
Study summary
The project is a national, prospective, multicenter pilot project. The project is focus on setting up the combined first trimester screening in the Czech Republic.
The combined first trimester screening is aimed at predicting and detecting the most serious obstetric complications, such as the great obstetrical syndromes (preeclampsia, fetal growth restriction, preterm labor and intrauterine fetal demise "IUFD") and structural congenital defects (morphological and chromosomal).
The primary objective of the project is to create a unified methodology for performing and evaluating the combined first trimester screening in connection with the National Health Information System (hereinafter referred to as "NHIS"), which will enable recording, providing analysis and linking recorded clinical parameters with data in the NHIS. The pilot project will also provide data for modeling appropriate mechanisms for reimbursement from public health insurance.
Eligibility
Primary outcome measure(s)
- Proportion of women with identified increased risk of Preeclampsia, Fetal Growth Restriction or Fetal Chromosomal Aneuploidies (trisomies of chromosomes 21, 18 and 13) — From June 2025 to October 2026
Trial sites (3)
| Facility | City | Region | Status |
|---|---|---|---|
| Regional Health Corpotarion - Most Hospital | Most | Czechia | Recruiting |
| University Hospital Olomouc | Olomouc | Czechia | Recruiting |
| Institute for the Care of Mother and Child | Prague | Czechia | Recruiting |
More Institute of Health Information and Statistics of the Czech Republic trials in Czechia
Other trials for the same condition
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07015203 on ClinicalTrials.gov ↗ ← All trials in Czechia